Navigation Links
Georgia State researchers shed light on fat burning
Date:2/5/2009

ATLANTA Researchers at Georgia State University have found that fat cells give feedback to the brain in order to regulate fat burning much the same way a thermostat regulates temperature inside a house.

With as increase in obesity threatening the health and life expectancies of people across the world, the research may help scientists better understand how weight is shed.

C. Kay Song and Tim Bartness of Georgia State, along with Gary J. Schwartz of the Albert Einstein College of Medicine, found that during the process of burning fat called lipolysis fat cells use sensory nerves to feed information to the brain.

Using viruses to trace communications in the nerves of Siberian hamsters, they found that the brain uses part of the nervous system used to regulate body functions, called the sympathetic nervous system, to in turn communicate back to the cells to initiate, continue or stop the fat burning depending upon the information the brain receives from the fat.

"The brain can trigger lipid burning by fat cells and through these sensory nerves, the fat cell can give the brain feedback," Bartness explained. "This is a really important concept in biology, as it can regulate the process of lipolysis much like how a thermostat regulates temperature in your house, using input from the air and output to a furnace or heating unit.

"The presence and function of the sensory nerves has been completely ignored and the areas in the brain that receive this sensory information were unknown until we did these studies," he said.

When the body has a low amount of a type of readily available fuel, a carbohydrate called glycogen, the body starts lipolysis to release energy stored in fats. At the end nerves which are part of the sympathetic nervous system, a chemical called norepinephrine is released to trigger the breakdown of fat.

Sensory nerves then appear to report back to the brain to inform it of the status of
'/>"/>

Contact: Jeremy Craig
jcraig@gsu.edu
404-413-1357
Georgia State University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. All Products at Georgia Peanut Plant Recalled
2. ProAssurance Receives Regulatory Approvals for Transactions with the PICA Group and Georgia Lawyers Insurance Company
3. Georgia Ranks Fourth in the Number of Untreated HIV Patients in the United States
4. Radiotherapy Clinics of Georgia and NewsTalk 750 WSB Team Up to Promote Prostate Proactivity
5. Justice Department Reaches Settlement With Georgia Regarding States Seven Psychiatric Hospitals
6. Hundreds of Uninsured Georgia School Children to Receive Free Eye Exams and Glasses
7. Ambulatory Services of America, Inc. Completes Purchase of Majority Interest in Rosa of Georgia, LLC
8. Specialists On Call Expands Access to Emergency Neurology On-Call Services in Georgia
9. Blue Cross and Blue Shield of Georgia Associates Pledge More Than $1.3 Million to Community Organizations
10. U.S. News & World Report Names Kaiser Permanente Top-Ranked Health Plan in Georgia
11. Georgia and South Carolina Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation 2Health News:Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation 3Health News:'That's My Hope' Audio Edition Released 2Health News:'That's My Hope' Audio Edition Released 3Health News:Saint Francis Medical Center Physician Services Implements MED3OOO RCM and ASP Services 2Health News:Saint Francis Medical Center Physician Services Implements MED3OOO RCM and ASP Services 3Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 2Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 3Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 4Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 5Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 6Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 7Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 8Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 9Health News:AND Calls on DoD to Open All Military Units to Women, Grant Parental Leave to Service Members 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 3
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2Fresh Blood Boosts Survival in Trauma Patients 58799 1Fresh Blood Boosts Survival in Trauma Patients 58799 2Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 1Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 2Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 3Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 4Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 5Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 1Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 2Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 3Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 4Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 5